The real‐world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine

Abstract

Higher dosages of opioid agonist therapies, especially for methadone maintenance treatment patients, appear to be associated with higher levels of treatment retention in Ukraine.